China announced on Monday that it was dropping centralized quarantine and most of its COVID-19 testing for inbound travelers from January 8, 2023. AmCham China’s Chairman Colm Rafferty and President Michael Hart…
As we look forward to 2023, we are taking a look back at what has been an eventful 2022. Between our 24th Annual Business Climate Survey Report, American Business in China White Paper,…
Down to Business: Ambassador Burns on Navigating the World’s Most Important Bilateral Relationship In early March 2022, the new US Ambassador to the People’s Republic of China, Nicholas Burns, touched down in…
Jing Wu on the New Direction of the Business Sustainability Committee Continuing the AmCham China Quarterly magazine’s series profiling AmCham China’s Board of Governors members and Committee Co-chairs, we spoke to the…
What a year! The pandemic and US-China tensions have contributed to rising uncertainties over China’s business environment. However, these unprecedented times have only made AmCham China’s role in supporting US and foreign…
By Arendse Huld China is in the process of shifting from “zero-COVID” to “living with COVID” by removing mandatory centralized quarantine, compulsory testing, and sweeping lockdowns. The reopening of the economy has…
On the afternoon of November 19, AmCham China Northeast Chapter, NBSO, EUCCC, and Maple Leaf Foreign Nationals organized a family mixer in Dalian. Opening remarks were delivered by Carolina de Velde, Chief…
AmCham China is pleased to announce that Colm Rafferty has been re-elected as Chair of the Board of Governors for 2023. Gloria Xu has been re-elected as Vice Chair, with Roberta Lipson…
On November 22, the AmCham China Northeast Chapter hosted “Dual Carbon Goals – A dialogue and forum on decarbonization”. Later on, during the afternoon of the same day, the Northeast Chapter also…
Following the conclusion of the Board of Governors Election, AmCham China is excited to announce the 2023 Board of Governors! Incumbents whose terms continue in 2023: Gloria Xu, Albemarle Allan Gabor, Merck…